Solution-Mediated Phase Transformation of Salts During Dissolution: Investigation Using Haloperidol as a Model Drug
Authors:
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 100 (7) , 2755-2768
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysisJournal of Pharmaceutical Sciences, 2010
- Solubility Advantage of Pharmaceutical CocrystalsCrystal Growth & Design, 2009
- Salt formation to improve drug solubilityAdvanced Drug Delivery Reviews, 2007
- Amorphization of Indomethacin by Co-Grinding with Neusilin US2: Amorphization Kinetics, Physical Stability and MechanismPharmaceutical Research, 2006
- IV-IVC considerations in the development of immediate-release oral dosage formJournal of Pharmaceutical Sciences, 2005
- Trends in Solubility of PolymorphsJournal of Pharmaceutical Sciences, 2005
- Ritonavir–PEG 8000Amorphous Solid Dispersions: In vitro and In vivo EvaluationsJournal of Pharmaceutical Sciences, 2004
- Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformationJournal of Pharmaceutical Sciences, 2001
- Salt form selection and characterization of LY333531 mesylate monohydrateInternational Journal of Pharmaceutics, 2000
- Characteristics and Significance of the Amorphous State in Pharmaceutical SystemsJournal of Pharmaceutical Sciences, 1997